Latest Financial Guidance And Forecasts News

Page 1 of 1

Bioxyne Secures Exclusive Rights to Launch Curaleaf’s Medical Cannabis Inhaler in Australia

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Ada Torres

3 Nov 2025

Top